Literature DB >> 27830986

Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model.

Kentaro Igarashi1,2,3, Kei Kawaguchi1,2, Tasuku Kiyuna1,2, Takashi Murakami1,2, Shinji Miwa3, Scott D Nelson4, Sarah M Dry4, Yunfeng Li4, Arun Singh5, Hiroaki Kimura3, Katsuhiro Hayashi3, Norio Yamamoto3, Hiroyuki Tsuchiya3, Fritz C Eilber6, Robert M Hoffman1,2.   

Abstract

Rhabdomyosarcoma (RMS) is a rare mesenchymal tumor. The aim of the present study was to develop a patient-derived orthotopic xenograft (PDOX) mouse model of RMS and compare the PDOX model to a subcutaneous (s.c.)-transplant model. A patient RMS from a striated muscle was grown orthotopically in the right biceps femoris muscle and right quadriceps muscle of nude mice to establish a PDOX model, as well as under the skin to establish an s.c. MODEL: PDOX tumors grew at a statistically-significant faster rate compared to the s.c. tumors. Recurrence after surgical resection occurred only in PDOX tumors, not in the s.c. MODEL: Histologically, only the PDOX model was shown to be invasive. In conclusion, these results indicate that the PDOX model of adult RMS is malignant and the subcutaneous model is benign. These results emphasize that a proper tumor microenvironment is necessary for patient-like behavior of a tumor in a mouse model.

Entities:  

Keywords:  PDOX; muscle; nude mouse; patient-derived orthotopic xenograft; recurrence; resection; rhabdomyosarcoma; subcutaneous; tumor growth rate

Mesh:

Year:  2016        PMID: 27830986      PMCID: PMC5270546          DOI: 10.1080/15384101.2016.1252885

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  Real-Time GFP Intravital Imaging of the Differences in Cellular and Angiogenic Behavior of Subcutaneous and Orthotopic Nude-Mouse Models of Human PC-3 Prostate Cancer.

Authors:  Yong Zhang; Makoto Toneri; Huaiyu Ma; Zhijian Yang; Michael Bouvet; Yusuke Goto; Naohiko Seki; Robert M Hoffman
Journal:  J Cell Biochem       Date:  2016-09-02       Impact factor: 4.429

2.  A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice.

Authors:  X Wang; X Fu; R M Hoffman
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

3.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

Review 4.  Roles of TGFbeta in metastasis.

Authors:  David Padua; Joan Massagué
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

Review 5.  Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.

Authors:  Andrea Ferrari; Palma Dileo; Michela Casanova; Rossella Bertulli; Cristina Meazza; Lorenza Gandola; Pierina Navarria; Paola Collini; Alessandro Gronchi; Patrizia Olmi; Franca Fossati-Bellani; Paolo G Casali
Journal:  Cancer       Date:  2003-08-01       Impact factor: 6.860

6.  Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and individual patient donors.

Authors:  T Furukawa; T Kubota; M Watanabe; M Kitajima; R M Hoffman
Journal:  Int J Cancer       Date:  1993-02-20       Impact factor: 7.396

7.  Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens.

Authors:  X Fu; R M Hoffman
Journal:  Anticancer Res       Date:  1993 Mar-Apr       Impact factor: 2.480

8.  Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.

Authors:  Yukihiko Hiroshima; Yong Zhang; Nan Zhang; Ali Maawy; Sumiyuki Mii; Mako Yamamoto; Fuminari Uehara; Shinji Miwa; Shuya Yano; Takashi Murakami; Masashi Momiyama; Takashi Chishima; Kuniya Tanaka; Yasushi Ichikawa; Michael Bouvet; Takuya Murata; Itaru Endo; Robert M Hoffman
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

9.  Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.

Authors:  Yukihiko Hiroshima; Ali Maawy; Yong Zhang; Takashi Murakami; Masashi Momiyama; Ryutaro Mori; Ryusei Matsuyama; Matthew H G Katz; Jason B Fleming; Takashi Chishima; Kuniya Tanaka; Yasushi Ichikawa; Itaru Endo; Robert M Hoffman; Michael Bouvet
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

10.  Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.

Authors:  Takashi Murakami; Arun S Singh; Tasuku Kiyuna; Sarah M Dry; Yunfeng Li; Aaron W James; Kentaro Igarashi; Kei Kawaguchi; Jonathan C DeLong; Yong Zhang; Yukihiko Hiroshima; Tara Russell; Mark A Eckardt; Jane Yanagawa; Noah Federman; Ryusei Matsuyama; Takashi Chishima; Kuniya Tanaka; Michael Bouvet; Itaru Endo; Fritz C Eilber; Robert M Hoffman
Journal:  Oncotarget       Date:  2016-07-26
View more
  19 in total

1.  Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.

Authors:  Kentaro Igarashi; Kei Kawaguchi; Tasuku Kiyuna; Kentaro Miyake; Takashi Higuchi; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Shree Ram Singh; Hiroyuki Tsuchiya; Robert M Hoffman
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

2.  Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.

Authors:  Kentaro Igarashi; Kei Kawaguchi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Shukuan Li; Qinghong Han; Yuying Tan; Ming Zhao; Yunfeng Li; Scott D Nelson; Sarah M Dry; Arun S Singh; Irmina A Elliott; Tara A Russell; Mark A Eckardt; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Tsuchiya; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-04-10       Impact factor: 4.534

3.  Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.

Authors:  Kei Kawaguchi; Kentaro Igarashi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Takashi Murakami; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Arun S Singh; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-03-29       Impact factor: 4.534

4.  PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.

Authors:  Takashi Higuchi; Jun Yamamoto; Norihiko Sugisawa; Yoshihiko Tashiro; Hiroto Nishino; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Kentaro Igarashi; Michael Bouvet; Shree Ram Singh; Hiroyuki Tsuchiya; Robert M Hoffman
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

5.  Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma.

Authors:  Tasuku Kiyuna; Yasunori Tome; Takashi Murakami; Ming Zhao; Kentaro Miyake; Kentaro Igarashi; Kei Kawaguchi; Masuyo Miyake; Hiromichi Oshiro; Takashi Higuchi; Yunfeng Li; Sarah M Dry; Scott D Nelson; Tara A Russell; Mark A Eckardt; Arun S Singh; Fuminori Kanaya; Fritz C Eilber; Robert M Hoffman
Journal:  J Cell Biochem       Date:  2018-06-22       Impact factor: 4.429

6.  Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical Trial.

Authors:  Tara A Russell; Mark A Eckardt; Takashi Murakami; Irmina A Elliott; Kei Kawaguchi; Tasuku Kiyuna; Kentaro Igarashi; Yungfeng Li; Joseph G Crompton; Danielle S Graham; Sarah M Dry; Nicholas Bernthal; Jane Yanagawa; Anusha Kalbasi; Noah Federman; Bartosz Chmielowski; Arun S Singh; Robert M Hoffman; Fritz C Eilber
Journal:  JCO Precis Oncol       Date:  2017-08-04

7.  Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models.

Authors:  Kei Kawaguchi; Kentaro Igarashi; Shukuan Li; Qinghong Han; Yuying Tan; Kentaro Miyake; Tasuku Kiyuna; Masuyo Miyake; Takashi Murakami; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Oncotarget       Date:  2017-12-12

8.  The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapy.

Authors:  Kentaro Miyake; Takashi Murakami; Tasuku Kiyuna; Kentaro Igarashi; Kei Kawaguchi; Masuyo Miyake; Yunfeng Li; Scott D Nelson; Sarah M Dry; Michael Bouvet; Irmina A Elliott; Tara A Russell; Arun S Singh; Mark A Eckardt; Yukihiko Hiroshima; Masashi Momiyama; Ryusei Matsuyama; Takashi Chishima; Itaru Endo; Fritz C Eilber; Robert M Hoffman
Journal:  Oncotarget       Date:  2017-09-08

Review 9.  Patient-derived xenograft models in musculoskeletal malignancies.

Authors:  Wan Lu; Tu Chao; Chen Ruiqi; Su Juan; Li Zhihong
Journal:  J Transl Med       Date:  2018-04-23       Impact factor: 5.531

10.  Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.

Authors:  Eunsung Jun; Seung-Mo Hong; Hyun Ju Yoo; Moon-Bo Kim; Ji Sun Won; Soyeon An; In Kyong Shim; Suhwan Chang; Robert M Hoffman; Song Cheol Kim
Journal:  Oncotarget       Date:  2017-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.